Physician profile
Reece A Everson
NPI 1255992731
$2,286.57
in general payments reported to CMS, 2019-2025
13 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $361 · 2023: $649 · 2024: $685 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $599.26 | 2022-2025 | Prophecy, Augment Injectable, Ortholoc 2 Lapifuse |
| Biotissue Holdings INC. | $537.75 | 2022-2025 | |
| Treace Medical Concepts, INC. | $388.19 | 2024-2025 | |
| Medtronic, INC. | $197.74 | 2022-2024 | Accurian |
| Organogenesis INC. | $167.28 | 2024-2025 | Puraply Wound Matrix |
| Smith+Nephew, INC. | $150.93 | 2022-2024 | Collagenase Santyl, Grafix, Regranex |
| Ossio INC | $63.35 | 2023 | |
| Bioventus LLC | $49.92 | 2024 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $42.86 | 2025 | Qutenza |
| Horizon Therapeutics Plc | $25.72 | 2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $25.54 | 2024 | A.L.P.S. |
| Vital Orthopedics LLC | $23.85 | 2025 | |
| Nvision Biomedical Technologies, INC. | $14.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reece Everson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.